Preventing Colorectal Cancer (PCC) has released the seventh issue brief in a series that underscores the importance of increasing U.S. colorectal cancer (CRC) screening rates. Issue Brief #7, Take Advantage of the Patient Protection and Affordable Care Act Preventive Care Clause, Get Screened for Colorectal Cancer via Colonoscopy, highlights the obstacles and opportunities that influence efforts to achieve this goal.
Preventing Colorectal Cancer (PCC) announces the recipients of the 2014 PCC Champion Award for Colorectal Cancer Prevention, an honor the not-for-profit organization established in 2011 to recognize individuals, groups and companies that provide either exceptionally high standards of care or that most effectively advocate for the prevention and early detection of colorectal cancer.
Randall Madry, Executive Director of Preventing Colorectal Cancer (PCC), will be in Portland on Friday, March 21st to award Cambia Health Solutions, the parent company of Regence Blue Cross Blue Shield and other health related companies with operations in the Pacific Northwest and nationally, with PCC’s Champions of Colorectal Cancer Prevention award. The award will be presented at 3PM at 200 SW Market Street, Portland, Oregon 97201. The presentation will occur in the conference room on the lobby level of the building.
Not-for-profit advocacy organization Preventing Colorectal Cancer (PCC) seeks nominations for the fourth annual Champion Awards of Colon Cancer Prevention to recognize individuals, groups and companies that provide either exceptionally high standards of care or who most effectively advocate for the prevention and early detection of colorectal cancer (CRC). Founded in 2008, PCC’s mission is to educate the public and key stakeholders about the opportunities to reduce the incidence of colorectal cancer through regular screening and care options for patients and their clinicians.
Preventing Colorectal Cancer (PCC) has released the sixth issue brief in a series that underscores the importance of increasing U.S. colorectal cancer (CRC) screening rates, and highlights the obstacles and opportunities that influence efforts to achieve this goal.
Issue Brief #5, The Impact of Health Insurance Reform on Colorectal Cancer, examines how the Patient Protection and Affordable Care Act (PPACA) expands Americans’ access to health care procedures such as colorectal cancer screening, which will lead to more people undergoing routine screening for colorectal cancer.
Preventing Colorectal Cancer (PCC) announces that Safeway, Inc. will be the recipient of the 2013 PCC Champion Award of Colon Cancer Prevention, an honor the not-for-profit organization established in 2011 to recognize individuals, groups and companies that provide either exceptionally high standards of care or that most effectively advocate for the prevention and early detection of colorectal cancer.
Preventing Colorectal Cancer (PCC) applauds the U.S. Departments of Labor, Health and Human Services (HHS), and the Treasury (the Departments) for determining that polyp removal should be a covered procedure in a provision of the Patient Protection and Affordable Care Act (PPACA) that requires coverage of preventive care, including screening colonoscopies, by insured and self-funded health benefit plans with no out-of-pocket cost to patients.
Non-profit advocacy organization Preventing Colorectal Cancer (PCC) is seeking nominations for the third annual Champion Awards of Colon Cancer Prevention to recognize individuals, groups and companies that provide either exceptionally high standards of care or who most effectively advocate for the prevention and early detection of colorectal cancer. Founded in 2008, PCC’s mission is to educate the public and key stakeholders about the opportunities to reduce the incidence of colorectal cancer through maintaining screening and care options for patients and their clinicians.
Preventing Colorectal Cancer (PCC) has released the fourth issue brief in a series designed to highlight the challenges and opportunities that exist with increasing the screening rates for colorectal cancer (CRC) in the United States. Titled, Why We Need Pricing Transparency, the brief provides an overview of the clinical and financial benefits of screening colonoscopies as a reliable screening tool to reduce the incidence of colon cancer.